MNTA - Momenta Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Momenta Pharmaceuticals's activity chart (see below) currently has 87 price targets and 64 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.09% with an average time for these price targets to be met of 234.32 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 30-Nov-2014.

Best performing analysts who are covering MNTA - Momenta Pharmaceuticals:

Danielle Brill Derek Archila Robyn Karnauskas Yanan Zhu Thomas Shrader

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Aug-2020

$50

5 years 10 months 18 days ago
(25-Aug-2020)

10/10 (100%)

$19.95 (66.39%)

197

Hold Since 24-Aug-2020

$45

5 years 10 months 19 days ago
(24-Aug-2020)

7/7 (100%)

$20.74 (85.49%)

287

Hold Since 07-Nov-2018

$52.5

$0.02 (0.04%)

$38

5 years 10 months 23 days ago
(20-Aug-2020)

3/4 (75%)

$0.39 (0.75%)

124

Buy Since 13-Sep-2018

$47

5 years 10 months 23 days ago
(20-Aug-2020)

4/4 (100%)

$18.45 (64.62%)

379

Buy Since 06-Nov-2019

$48

5 years 10 months 24 days ago
(19-Aug-2020)

2/2 (100%)

$12.35 (34.64%)

85

Show more analysts

Please expand the browser size to see the chart

What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?

On average it took 234.32 days on average for the stock forecasts to be realized with a an average price target met ratio 94.09

Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?

Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?

has 0 price targets and 0 ratings on MNTA

Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?

Robyn Karnauskas with highest potential upside - $4.52

Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?

Dana Flanders with lowest potential downside - -$38.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?